These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

274 related items for PubMed ID: 16257362

  • 41. Comparison of age-specific incidence rate patterns for different histopathologic types of breast carcinoma.
    Anderson WF, Chu KC, Chang S, Sherman ME.
    Cancer Epidemiol Biomarkers Prev; 2004 Jul; 13(7):1128-35. PubMed ID: 15247123
    [Abstract] [Full Text] [Related]

  • 42. Comparison of cancer registry and clinical data as predictors for breast cancer survival.
    Seppänen J, Heinävaara S, Holli K, Hakulinen T.
    Cancer Causes Control; 2008 Dec; 19(10):1299-304. PubMed ID: 18752035
    [Abstract] [Full Text] [Related]

  • 43. Epidemiology of breast cancer in women in Jordan: patient characteristics and survival analysis.
    Arkoob K, Al-Nsour M, Al-Nemry O, Al-Hajawi B.
    East Mediterr Health J; 2010 Oct; 16(10):1032-8. PubMed ID: 21222418
    [Abstract] [Full Text] [Related]

  • 44. Randomized phase 3 trial of fluorouracil, epirubicin, and cyclophosphamide alone or followed by Paclitaxel for early breast cancer.
    Martín M, Rodríguez-Lescure A, Ruiz A, Alba E, Calvo L, Ruiz-Borrego M, Munárriz B, Rodríguez CA, Crespo C, de Alava E, López García-Asenjo JA, Guitián MD, Almenar S, González-Palacios JF, Vera F, Palacios J, Ramos M, Gracia Marco JM, Lluch A, Alvarez I, Seguí MA, Mayordomo JI, Antón A, Baena JM, Plazaola A, Modolell A, Pelegrí A, Mel JR, Aranda E, Adrover E, Alvarez JV, García Puche JL, Sánchez-Rovira P, Gonzalez S, López-Vega JM, GEICAM 9906 Study Investigators.
    J Natl Cancer Inst; 2008 Jun 04; 100(11):805-14. PubMed ID: 18505968
    [Abstract] [Full Text] [Related]

  • 45. Secular trends in the use, quality, and outcomes of gastrectomy for noncardia gastric cancer in the United States.
    Le A, Berger D, Lau M, El-Serag HB.
    Ann Surg Oncol; 2007 Sep 04; 14(9):2519-27. PubMed ID: 17610016
    [Abstract] [Full Text] [Related]

  • 46. Risk of invasive breast carcinoma among women diagnosed with ductal carcinoma in situ and lobular carcinoma in situ, 1988-2001.
    Li CI, Malone KE, Saltzman BS, Daling JR.
    Cancer; 2006 May 15; 106(10):2104-12. PubMed ID: 16604564
    [Abstract] [Full Text] [Related]

  • 47. Patterns of dementia diagnosis in surveillance, epidemiology, and end results breast cancer survivors who use chemotherapy.
    Heck JE, Albert SM, Franco R, Gorin SS.
    J Am Geriatr Soc; 2008 Sep 15; 56(9):1687-92. PubMed ID: 18691280
    [Abstract] [Full Text] [Related]

  • 48. [Clinical characteristics and prognosis of breast cancer patients with vascular invasion].
    Zhao WH, Xu BH, Zhang P, Li Q, Zhao LM, Sun Y.
    Zhonghua Zhong Liu Za Zhi; 2007 Feb 15; 29(2):137-40. PubMed ID: 17645853
    [Abstract] [Full Text] [Related]

  • 49. Ethnic differences in breast cancer in Hawai'i: age, stage, hormone receptor status, and survival.
    Braun KL, Fong M, Gotay CC, Chong CD.
    Pac Health Dialog; 2004 Sep 15; 11(2):146-53. PubMed ID: 16281692
    [Abstract] [Full Text] [Related]

  • 50. [Breast cancer in men: are there similarities with breast cancer in women?].
    Arnould N, Pouget O, Gharbi M, Brettes JP.
    Gynecol Obstet Fertil; 2006 May 15; 34(5):413-9. PubMed ID: 16630739
    [Abstract] [Full Text] [Related]

  • 51. Chinese female breast cancer patients show a better overall survival than their male counterparts.
    Xia LP, Zhou FF, Guo GF, Wang F, Wang X, Yuan ZY, Zhang B.
    Chin Med J (Engl); 2010 Sep 15; 123(17):2347-52. PubMed ID: 21034547
    [Abstract] [Full Text] [Related]

  • 52. Outcomes of women with metachronous breast and ovarian carcinomas.
    Liou WS, Hamilton CA, Cheung MK, Osann K, Longacre TA, Teng NN, Husain A, Dirbas FM, Chan JK.
    Gynecol Oncol; 2006 Oct 15; 103(1):190-4. PubMed ID: 16569424
    [Abstract] [Full Text] [Related]

  • 53. Ductal carcinoma in situ: trends in geographic, temporal, and demographic patterns of care and survival.
    Joslyn SA.
    Breast J; 2006 Oct 15; 12(1):20-7. PubMed ID: 16409583
    [Abstract] [Full Text] [Related]

  • 54. Poor outcome of hormone receptor-positive breast cancer at very young age is due to tamoxifen resistance: nationwide survival data in Korea--a report from the Korean Breast Cancer Society.
    Ahn SH, Son BH, Kim SW, Kim SI, Jeong J, Ko SS, Han W, Korean Breast Cancer Society.
    J Clin Oncol; 2007 Jun 10; 25(17):2360-8. PubMed ID: 17515570
    [Abstract] [Full Text] [Related]

  • 55. Trends in the incidence and treatment of parathyroid cancer in the United States.
    Lee PK, Jarosek SL, Virnig BA, Evasovich M, Tuttle TM.
    Cancer; 2007 May 01; 109(9):1736-41. PubMed ID: 17372919
    [Abstract] [Full Text] [Related]

  • 56. Prognostic value of pathologic complete response after primary chemotherapy in relation to hormone receptor status and other factors.
    Guarneri V, Broglio K, Kau SW, Cristofanilli M, Buzdar AU, Valero V, Buchholz T, Meric F, Middleton L, Hortobagyi GN, Gonzalez-Angulo AM.
    J Clin Oncol; 2006 Mar 01; 24(7):1037-44. PubMed ID: 16505422
    [Abstract] [Full Text] [Related]

  • 57. Incidence and survival of pancreatic head and body and tail cancers: a population-based study in the United States.
    Lau MK, Davila JA, Shaib YH.
    Pancreas; 2010 May 01; 39(4):458-62. PubMed ID: 19924019
    [Abstract] [Full Text] [Related]

  • 58. Positive progesterone receptors and cell proliferation index: an independent association with breast cancer in males.
    Piñero A, Ferri B, Polo L, Canteras M, Sola J, Bermejo J.
    Breast; 2010 Apr 01; 19(2):133-6. PubMed ID: 20117933
    [Abstract] [Full Text] [Related]

  • 59. Prognostic value of morphology and hormone receptor status in breast cancer - a population-based study.
    Allemani C, Sant M, Berrino F, Aareleid T, Chaplain G, Coebergh JW, Colonna M, Contiero P, Danzon A, Federico M, Gafà L, Grosclaude P, Hédelin G, Macè-Lesech J, Garcia CM, Paci E, Raverdy N, Tretarre B, Williams EM.
    Br J Cancer; 2004 Oct 04; 91(7):1263-8. PubMed ID: 15365566
    [Abstract] [Full Text] [Related]

  • 60. Differences in male breast cancer stage, tumor size at diagnosis, and survival rate between metropolitan and nonmetropolitan regions.
    Klein J, Ji M, Rea NK, Stoodt G.
    Am J Mens Health; 2011 Sep 04; 5(5):430-7. PubMed ID: 21411477
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 14.